INFERRE CONSULTING

TITAN

Trans-splicing Intein Therapeutics for AAV-enabled Next-generation proteins

We are a biotech start-up, based in Basel, Switzerland, developing a specialized platform for large Adeno-Associated Virus (AAV) -based therapies enabled by split-intein protein engineering and zebrafish translational screening.

We are inviting investor to collaborate with us to accelerate our Proof of Concept

FOUNDERS

Santoro Di Franco
Master in International Trade
LinkedIn

Santoro, Co-Founder of TITAN, specializes in building and scaling strategic partnerships in health innovation, connecting stakeholders to drive execution-focused, impactful collaborations.

Dr. Avisek Ghose
Ph.D Biophysics
LinkedIn

Avisek, Co-Founder of TITAN, drives market access and commercialization strategies to help innovative healthcare solutions reach patients faster and scale sustainably.

Dr. Yury Makhankov
MD, Ph.D, Medical Affair
LinkedIn

Yury, Advisor to TITAN drives clinical and medical strategy in rare diseases to accelerate access, strengthen evidence, and improve patient outcomes globally.